Catalyst CEO Patrick J. McEnany to retire by end of 2023; remains Chairman

CATALYST PHARMACEUTICALS, INC.

CEO Patrick J. McEnany informed board of intention to retire as CEO by end of 2023.
McEnany will continue as non-executive Chairman of the Board after retirement.
Board has retained a nationally recognized executive recruitment firm to find successor.
McEnany stated retirement not due to any disagreement with management or board.
McEnany remains Catalyst's largest individual stockholder.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Patrick J. McEnany

Chief Executive Officer

CPRX · CATALYST PHARMACEUTICALS, INC.

Filed: July 28, 2023, 7:59 PM ET

On July 24, 2023, Patrick J. McEnany, the Company’s Chief Executive Officer (“CEO”), informed the Company’s Board of Directors that he intends to retire as the Company’s CEO by the end of 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Patrick J. McEnany retired as Chief Executive Officer at CATALYST PHARMACEUTICALS, INC..

Action: retired
Role: Chief Executive Officer

Exact text from the filing

On July 24, 2023, Patrick J. McEnany, the Company’s Chief Executive Officer (“CEO”), informed the Company’s Board of Directors that he intends to retire as the Company’s CEO by the end of 2023.

View on SEC.gov

CATALYST PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-23-197742

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.